Merck & Co. Inc. buy Scotiabank
Start price
14.11.25
/
50%
€78.80
Target price
14.11.26
-
Performance (%)
14.97%
Price
29.01.26
€90.60
Summary
This prediction is currently active. The BUY prediction by Scotiabank currently has a performance of 14.97%. This prediction currently runs until 14.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Merck & Co. Inc. | -2.581% | -2.581% |
| iShares Core DAX® | -1.410% | 0.471% |
| iShares Nasdaq 100 | -0.450% | -0.305% |
| iShares Nikkei 225® | -0.224% | 5.529% |
| iShares S&P 500 | -1.095% | -0.774% |
Comments by Scotiabank for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE:MRK) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat